Abstract:Human structural congenital malformations are the leading cause of infant mortality in the United States. Estimates from the United States Center for Disease Control and Prevention (CDC) determine that close to 3% of all United States newborns present with birth defects; the worldwide estimate approaches 6% of infants presenting with congenital anomalies. The scientific community has recognized for decades that the majority of birth defects have undetermined etiologies, although we propose that environmental agents interacting with inherited susceptibility genes are the major contributing factors. Neural tube defects (NTDs) are among the most prevalent human birth defects and as such, these malformations will be the primary focus of this review. NTDs result from failures in embryonic central nervous system development and are classified by their anatomical locations. Defects in the posterior portion of the neural tube are referred to as meningomyeloceles (spina bifida), while the more anterior defects are differentiated as anencephaly, encephalocele, or iniencephaly. Craniorachischisis involves a failure of the neural folds to elevate and thus disrupt the entire length of the neural tube. Worldwide NTDs have a prevalence of approximately 18.6 per 10,000 live births. It is widely believed that genetic factors are responsible for some 70% of NTDs, while the intrauterine environment tips the balance toward neurulation failure in at risk individuals. Despite aggressive educational campaigns to inform the public about folic acid supplementation and the benefits of providing mandatory folic acid food fortification in the United States, NTDs still affect up to 2,300 United States births annually and some 166,000 spina bifida patients currently live in the United States, more than half of whom are now adults. Within the context of this review, we will consider the role of maternal nutritional status (deficiency states involving B vitamins and one carbon analytes) and the potential modifiers of NTD risk beyond folic acid. There are several well-established human teratogens that contribute to the population burden of NTDs, including: industrial waste and pollutants [e.g., arsenic, pesticides, and polycyclic aromatic hydrocarbons (PAHs)], pharmaceuticals (e.g., anti-epileptic medications), and maternal hyperthermia during the first trimester. Animal models for these teratogens are described with attention focused on valproic acid (VPA; Depakote). Genetic interrogation of model systems involving VPA will be used as a model approach to discerning susceptibility factors that define the gene-environment interactions contributing to the etiology of NTDs.

Epigenetic regulation by TET1 in gene-environmental interactions influencing susceptibility to congenital malformations

Abnormal transcriptome-wide DNA demethylation induced by folate deficiency causes neural tube defects

A unique methylation pattern co-segregates with neural tube defect statuses in Han Chinese pedigrees

Gene Environment Interactions in the Etiology of Neural Tube Defects

Fetal DNA Hypermethylation in Tight Junction Pathway is Associated with Neural Tube Defects: A Genome-Wide DNA Methylation Analysis

Nutrition, One-Carbon Metabolism and Neural Tube Defects: A Review

Network correlation analysis revealed potential new mechanisms for neural tube defects beyond folic acid.

Association of Neural Tube Defects with Maternal Alterations and Genetic Polymorphisms in One-Carbon Metabolic Pathway

Neural Tube Defects and Disturbed Maternal Folate- and Homocysteine-Mediated One-Carbon Metabolism

Tissue-specific Distribution of Aberrant DNA Methylation Associated with Maternal Low-Folate Status in Human Neural Tube Defects

Association between MTHFD1 G1958A polymorphism and neural tube defects susceptibility: a meta-analysis.

Relation Between Hypomethylation of Long Interspersed Nucleotide Elements and Risk of Neural Tube Defects

Folate deficiency reduced aberrant level of DOT1L-mediated histone H3K79 methylation causes disruptive SHH gene expression involved in neural tube defects

High Ratios Of C20:4n-6/C20:5n-3 And Thromboxane B-2/6-Keto-Prostaglandin F-1 Alpha In Placenta Are Potential Risk Contributors For Neural Tube Defects: A Case-Control Study In Shanxi Province, China

Neural tube defects and epigenetics: role of histone post-translational histone modifications

Low Folate Concentration Impacts Mismatch Repair Deficiency in Neural Tube Defects

Association Of The Maternal Mthfr C677t Polymorphism With Susceptibility To Neural Tube Defects In Offsprings: Evidence From 25 Case-Control Studies

Linking genetics to epigenetics: The role of folate and folate-related pathways in neurodevelopmental disorders

Maternal Folic Acid Supplementation Mediates Offspring Health via DNA Methylation

Double whammy: the genetic variants in CECR2 and high Hcy on the development of neural tube defects

Global DNA Hypomethylation is Associated with NTD-affected Pregnancy: A Case-Control Study.